Researchers at the Peter Mac Institute have found an answer to a decades-old question about cell function that could lead to improved cancer treatments in the future.
Simone Steger's team's discovery could help develop a treatment for the most serious form of leishmaniasis. Leishmaniasis is a tropical disease affecting an increasing number of people around the world.
Researchers from Birmingham have shown that PEPITEM, a naturally occurring peptide (small protein), holds promise as a new therapeutic agent for the treatment of osteoporosis and other bone loss disorders, with clear advantages over existing drugs.
The tool classifies Alzheimer's disease cases into three subtypes based on the location of changes in the brain and builds on the team's previous work by showing how these changes affect people differently.
Certain inflammatory proteins—substances that are released as part of the immune response—peak at different times of the day depending on whether mothers are breastfeeding, expressing milk, or formula feeding.
